ArticleCancer research communications2024

De Novo Purine Metabolism is a Metabolic Vulnerability of Cancers with Low p16 Expression.

Naveen Kumar Tangudu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.